Screening compound: QLDNXTJMWOENDQ-UHFFFAOYSA-N

Screening compound: QLDNXTJMWOENDQ-UHFFFAOYSA-N
Screening compound: QLDNXTJMWOENDQ-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
QLDNXTJMWOENDQ-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J030-1011

Molecular Formula

C29H33N5O4S (C29 H33 N5 O4 S)

Compound Name

8-methyl-2-[(4-methylpiperidino)sulfonyl]-3-[4-(2-pyridyl)piperazino]dibenzo[b,f][1,4]oxazepin-11(10H)-one

IUPAC name

6-methyl-13-[(4-methylpiperidin-1-yl)sulfonyl]-14-[4-(pyridin-2-yl)piperazin-1-yl]-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(15)3571113-hexaen-10-one

SMILES

CC(CC1)CCN1S(c(cc(c(Oc(ccc(C)c1)c1N1)c2)C1=O)c2N(CC1)CCN1c1ncccc1)(=O)=O

InChI

InChI=1S/C29H33N5O4S/c1-20-8-11-34(12-9-20)39(36,37)27-18-22-26(38-25-7-6-21(2)17-23(25)31-29(22)35)19-24(27)32-13-15-33(16-14-32)28-5-3-4-10-30-28/h3-7,10,17-20H,8-9,11-16H2,1-2H3,(H,31,35)

InChI Key

QLDNXTJMWOENDQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27220485

QLDNXTJMWOENDQ-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-infective Library (19449 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein-Protein Interaction Library (218420 compounds)

Epigenetics Focused Set (26518 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with QLDNXTJMWOENDQ-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound QLDNXTJMWOENDQ-UHFFFAOYSA-N?
Check Price and Availability of QLDNXTJMWOENDQ-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of QLDNXTJMWOENDQ-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for QLDNXTJMWOENDQ-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for QLDNXTJMWOENDQ-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of QLDNXTJMWOENDQ-UHFFFAOYSA-N available by request